GHK-Cu HPLC and Mass Spectrometry: What the Methods Can Show

Disclosure: Peptide Bio Index is affiliated with SourcePoint Research and may earn from qualifying purchases or affiliate links.

This guide summarizes what the provided peer-reviewed literature reports about GHK-Cu and highlights what the reviewed records do — and do not — document about analytical characterization suitable for COAs. The reviewed sources describe GHK (glycyl‑L‑histidyl‑L‑lysine) and its copper(II) chelate (GHK‑Cu) as a biologically active copper‑binding peptide used in wound‑healing and cosmetic contexts, with preclinical evidence for tissue remodeling and angiogenesis (see S1, S2, S8, S4).

What the reviewed literature reports about GHK-Cu

The reviewed articles report that GHK is a small human peptide (glycyl‑L‑histidyl‑L‑lysine) that forms a high‑affinity chelate with copper (GHK‑Cu) and has been studied for tissue remodeling, wound healing, and anti‑inflammatory actions; it has been used in cosmetic products and studied in preclinical wound models (see S1, S2, S4, S8). ^{[S1] [S2] [S4] [S8]}

Evidence gaps in the reviewed records for HPLC and mass spectrometry

None of the provided reviewed source excerpts include primary analytical data (HPLC chromatograms, mass spectra, instrument/method descriptions, or COA‑level chromatogram/spectrum files) for GHK‑Cu. Therefore, the reviewed literature set does not document how HPLC or MS were applied to confirm identity, purity, copper stoichiometry, or batch‑level characteristics for specific GHK‑Cu materials.

Implications for interpreting COAs and supplier documentation

The literature highlights preclinical and cosmetic use of GHK‑Cu but also emphasizes limited clinical evidence and variable reporting in the public literature. Reviews note widespread cosmetic use with limited published clinical studies and incomplete reporting on physicochemical properties and skin permeability (S4). Broader reviews emphasize that rigorous human clinical data are scarce for many peptides including GHK‑Cu and warn of a marketplace of unapproved products where documentation and validated testing may be inconsistent (S5, S6, S7). A specific preclinical study reported improved wound healing using GHK‑Cu‑loaded liposomes in mice (S8). Given these points, COAs and supplier documentation should be checked carefully for method details, batch identifiers, and explicit analytical evidence rather than assuming standardized testing across vendors (S4, S5, S6, S7). ^{[S4] [S5] [S6] [S7] [S8] [S2]}

Practical documentation items to request when HPLC/MS data are absent

If a COA lacks HPLC chromatograms or MS spectra, request (1) the raw chromatogram and integration report, (2) the full MS data file and annotated spectrum with expected m/z assignments, (3) method parameters (column, solvent, gradient, detection), (4) calibration/standards used for copper quantification and peptide identity, and (5) a statement tying the tested sample back to the shipped batch (lot number and sample label). These are neutral documentation items to improve traceability and analytical confidence.

Limitations and research gaps

• The reviewed source excerpts do not contain HPLC chromatograms, mass spectra, or method parameters for GHK‑Cu; therefore this guide cannot summarize specific chromatographic retention times, MS m/z values, or validated analytical methods for GHK‑Cu from the provided records.
• No reviewed source provides batch‑specific COA data, so this guide cannot confirm whether any specific supplier lot passed a particular analytical test.
• Most cited evidence in the provided records is preclinical or review‑level; clinical evidence and standardized analytical reporting for GHK‑Cu are limited in the reviewed set.
• Because analytical‑method details (instrument type, column chemistry, mobile phases, ionization mode, calibration standards) are absent from the reviewed excerpts, statements about HPLC/MS performance or limits of detection would be speculative and are not included here.

Documentation checklist

• Verify the COA lists the material’s declared identity (sequence: glycyl-L-histidyl-L-lysine or 'GHK') and the stated copper complex (e.g., 'GHK-Cu' or copper(II) chelate).
• Confirm a batch/lot number, COA date, and an analyst or laboratory stamp for traceability.
• Look for an HPLC chromatogram or stated HPLC method (column, mobile phase, gradient, detection wavelength) and a stated % purity. If absent, flag the COA for incomplete analytical information.
• Look for mass spectrometry data (MS spectrum, m/z values) and a description of the instrument/method (ionization type, expected m/z for the peptide and for copper-containing species).
• Check whether the COA lists copper content or stoichiometry (e.g., molar ratio GHK:Cu) and whether this was measured or assumed.
• Confirm acceptance criteria and how they were applied (e.g., purity cutoff, allowable related-impurity peaks, identity confirmation criteria).
• Seek method-validation notes on the COA or accompanying documentation (limits of detection, calibration standards, reference material used).
• Check sample-handling and storage conditions on the COA or accompanying documentation (storage temperature, stabilization steps), and whether the tested sample matches the shipped batch.
• If MS data are provided, look for isotope pattern consistency for copper-containing species and for any reported adducts (e.g., sodium, potassium) that affect m/z interpretation.
• If HPLC purity is reported, request the raw chromatogram when possible to evaluate baseline, resolved impurity peaks, and integration method.

Related research supplies

• COA template form (fields for batch/lot, analyst, method descriptions, acceptance criteria)
• Sample receipt and storage log (for batch traceability)
• Temperature‑monitoring stickers or data loggers for stored samples
• Laboratory information management system (LIMS) entries or batch records
• Cataloguing labels and inventory tags for batch/lot control
• Certified laboratory wipes and surface cleaners for documentation of work areas

Sources and references

1. [S1] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.. International journal of molecular sciences. 2018. PMID: 29986520. DOI: 10.3390/ijms19071987
2. [S2] Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide.. Aging pathobiology and therapeutics. 2020. PMID: 35083444. DOI: 10.31491/apt.2020.03.014
3. [S3] Rahman OF, Lee SJ, Seeds WA. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews. 2026. PMID: 41490200. DOI: 10.5435/JAAOSGlobal-D-25-00236
4. [S4] Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.. BioImpacts : BI. 2025. PMID: 39963574. DOI: 10.34172/bi.30071
5. [S5] Mayfield CK, Bolia IK, Feingold CL, Lin EH, Liu JN, Rick Hatch GF. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.. The American journal of sports medicine. 2026. PMID: 41476424. DOI: 10.1177/03635465251357593
6. [S6] Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.. Sports medicine (Auckland, N.Z.). 2026. PMID: 41966639. DOI: 10.1007/s40279-026-02437-0
7. [S7] Tewari K, Liu TP, Im C, Hamad C, Petrigliano F, Cheung EC. Peptide Supplements and Their Therapeutic Applications in Sports Medicine.. The American journal of sports medicine. 2026. PMID: 42578445. DOI: 10.1177/03635465261464420
8. [S8] Wang X, Liu B, Xu Q, Sun H, Shi M, Wang D. GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis.. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2017. PMID: 28370978. DOI: 10.1111/wrr.12520

Peptide Bio Index is affiliated with SourcePoint Research. Articles may link to SourcePointResearch.com and third-party affiliate products. As an Amazon Associate, Peptide Bio Index earns from qualifying purchases. Content is educational and research-literature focused only and is not medical advice, dosing guidance, or a personal-use recommendation.